期刊文献+

Probiotics and Their Metabolites Ameliorate Inflammatory Bowel Disease:A Critical Review 被引量:2

原文传递
导出
摘要 Crohn disease and ulcerative colitis are the two main manifestations of inflammatory bowel disease(IBD),and both are highly morbid.However,the precise etiology of IBD is still unknown and effective therapeutics are yet to be discovered.It is becoming increasingly clear that a combination of factors,including genetic background,host immune response,and microbial reduced diversity status are related to IBD.The cardinal symptom of IBD patients is the imbalance of the intestinal microflora.According to previous studies,both probiotics and symbiotic microbiota can play a protective role through intestinal micro-ecosystem regulation,epithelial barrier integrity enhancement,and inflammation reduction.Therefore,probiotics can provide an alternative or auxiliary method to traditional IBD treatment.Here,we reviewed the possible pathogenesis of IBD,summarized the possible mechanisms of probiotics modulation of IBD,and emphasized the prevention and treatment targets of probiotics-mediated IBD,with the aim to provide theoretical support for the treatment of IBD patients by probiotics in clinical trials.
出处 《Infectious Microbes & Diseases》 2021年第1期4-13,共10页 感染微生物与疾病(英文)
基金 the Key Research and Development Program of Zhejiang Province(No.2020C04002) the National Natural Science Foundation of China(No.31972974,No.31871775) the Chinese Academy of Engineering Academy-Locality Cooperation Project(2019-ZJ-JS-02)。
  • 相关文献

参考文献1

共引文献44

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部